Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

735.00p
   
  • Change Today:
    -21.50p
  • 52 Week High: 1,717.00
  • 52 Week Low: 576.50
  • Currency: UK Pounds
  • Shares Issued: 124.66m
  • Volume: 304,110
  • Market Cap: £916.22m
  • RiskGrade: 314
  • Beta: 0.04

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 647.00 (173.00) 40.00¢ 17.6 n/a -67% n/a 0.0%
31-Dec-21 791.00 190.00 19.20¢ 86.7 n/a -52% n/a 0.0%
31-Dec-22 901.00 (95.00) (38.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1,093.00 1.00 1.00¢ 1,535.7 n/a n/a n/a 0.0%
31-Dec-24 1,188.00 (43.00) (36.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,046.32 239.33 100.29p 7.3 n/a n/a n/a 0.0%
31-Dec-26 1,090.86 264.30 116.65p 6.3 0.4 +16% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 18.58 n/a 304.78 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Indivior Market Data

Currency UK Pounds
Share Price 735.00p
Change Today -21.50p
% Change -2.84 %
52 Week High 1,717.00
52 Week Low 576.50
Volume 304,110
Shares Issued 124.66m
Market Cap £916.22m
Beta 0.04
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.22% below the market average54.22% below the market average54.22% below the market average54.22% below the market average54.22% below the market average
44.68% above the sector average44.68% above the sector average44.68% above the sector average44.68% above the sector average44.68% above the sector average
Price Trend
68.40% above the market average68.40% above the market average68.40% above the market average68.40% above the market average68.40% above the market average
10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average
Income Not Available
Growth
51.93% above the market average51.93% above the market average51.93% above the market average51.93% above the market average51.93% above the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 28-Mar-2025

Time Volume / Share Price
16:35 177,059 @ 735.00p
16:35 1,091 @ 735.00p
16:35 1,224 @ 735.00p
16:35 1,229 @ 735.00p
16:35 3,635 @ 735.00p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page